AIR Asset Management Hosts Successful Second Annual Private Life Settlement Symposium
The event marked a significant milestone for the industry, as the Symposium provided attendees with an investment-focused setting that brought together key industry players with active and prospective investors.
"We are thrilled to witness the momentum and education sharing during our second annual Private Life Settlement Symposium," said
The Symposium provided a comprehensive overview of the asset class, the latest secondary market data from the Life Insurance Settlement Association (LISA), AIR's unique multi-strategy approach to longevity investing, investment structures, and life expectancy concepts and developments.
Attendees heard valuable information directly from industry sources. One element remains clear; life settlements continue to provide financial benefits to seniors. LISA reported that its provider members achieved an average multiple of 5.2 on the price paid to consumers compared to what they would have received by surrendering their policies directly to the life insurance company. This represents a significant financial advantage for seniors. The report also highlighted that LISA provider members paid approximately
In addition to the insightful discussions about the market, the Symposium featured sessions on investing. These investment-focused sessions highlighted how AIR's approach to life settlements, through its multi-strategy, provides equity-like returns with bond-like volatility, offering investors much-needed diversification to weather storms like 2022. Hearing directly from the managers about AIR's complementary strategies, such as law firm lending and lower middle-market lending, showcased the opportunity to allocate to life settlements while providing investors with a valuable alternative for individuals seeking to diversify their portfolios, preserve capital, and increase risk-adjusted returns.
"One of the highlights of the Symposium was the meticulous analysis of mortality rate variations among different cohorts. In-depth discussions illuminated these variations' implications and potential impacts, offering attendees a unique insight into life expectancy estimation's intricacies. This exploration of mortality trends proved invaluable for industry professionals and investors seeking to make informed decisions in the life settlement market," said
The Symposium attracted esteemed participants, including sizeable registered investment advisory firms, institutions, consultants, and high-net-worth individuals. Prominent industry participants such as Abacus Life, Life Insurance Settlement Association (LISA), Coventry, Q Capital Strategies, Life Equity, Carlisle Management Company, ISC Services, Longevity Asset Advisors, Lapetus Solutions, Predictive Resources, Life Insurance Settlements, and others were in attendance. Additionally, representatives from AIR Asset Management's esteemed partners and service providers, including EisnerAmper, Sadis & Goldberg, Aegis, Kerberos Capital Management, Star Mountain Capital, and a handful more, joined the event.
Beyond the insightful content shared during presentations and discussions, attendees had numerous opportunities to network, exchange knowledge, and interact with the AIR Asset Management team. Networking events included a Lake Michigan Boat Cruise to see the famous
About AIR Asset Management
AIR Asset Management ("AIRAM") is a rapidly growing SEC-registered hedge fund management firm with approximately
For more information about AIR Asset Management, please visit www.airassetmanagement.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/air-asset-management-hosts-successful-second-annual-private-life-settlement-symposium-301861136.html
SOURCE AIR Asset Management
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BitGo acquires NYDIG's institutional trading business
- ATTACK SHARK Unveils R86 HE Carbon Fiber Magnetic Switch Gaming Keyboard, Redefining the 75% Competitive Keyboard Experience
- NeOnc reports Phase 2a brain cancer trial results, plans FDA meeting
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Hedge FundsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share